Terms: = Lung cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
80 results:
1. foxa1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract] [Full Text] [Related]
2.
Xu C; Li Y; Pan J; Wang S; Ye Z; Cai X; Zheng H; Yin Z; Cao Z
Discov Med; 2024 Jan; 36(180):82-90. PubMed ID: 38273748
[TBL] [Abstract] [Full Text] [Related]
3. Small Cell lung cancer Plasticity Enables NFIB-Independent Metastasis.
Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma.
Abatti LE; Lado-Fernández P; Huynh L; Collado M; Hoffman MM; Mitchell JA
Nucleic Acids Res; 2023 Oct; 51(19):10109-10131. PubMed ID: 37738673
[TBL] [Abstract] [Full Text] [Related]
5. A Druggable foxa1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell lung cancer.
Dorso M; Patel PT; Pankov A; Boyer JA; Soni RK; Del Priore IS; Hayatt O; Kulick A; Hagen CJ; de Stanchina E; Junttila MR; Daemen A; Friedman LS; Hendrickson RC; Chandarlapaty S
Cancer Res Commun; 2023 Sep; 3(9):1788-1799. PubMed ID: 37691854
[TBL] [Abstract] [Full Text] [Related]
6. foxa1 prolongs S phase and promotes cancer progression in non-small cell lung cancer through upregulation of CDC5L and activation of the ERK1/2 and JAK2 pathways.
Chen G; Wei RS; Ma J; Li XH; Feng L; Yu JR
Kaohsiung J Med Sci; 2023 Nov; 39(11):1077-1086. PubMed ID: 37658700
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA SOX2-OT enhances cancer biological traits via sponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma.
Dodangeh F; Sadeghi Z; Maleki P; Raheb J
Sci Rep; 2023 Jul; 13(1):12371. PubMed ID: 37524903
[TBL] [Abstract] [Full Text] [Related]
8. foxa1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.
Wei J; Yu H; Liu T; Wang Z; Lang C; Pan Y
Thorac Cancer; 2023 Jul; 14(21):2026-2037. PubMed ID: 37277890
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.
Peng TR; Liao PF; Wu TW
Thorac Cancer; 2023 Apr; 14(10):929-939. PubMed ID: 36908264
[TBL] [Abstract] [Full Text] [Related]
10. foxa1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma.
Li J; Zhang Y; Wang L; Li M; Yang J; Chen P; Zhu J; Li X; Zeng Z; Li G; Xiong W; McCarthy JB; Xiang B; Yi M
Cell Death Dis; 2022 Aug; 13(8):711. PubMed ID: 35974000
[TBL] [Abstract] [Full Text] [Related]
11. Modest increase of KIF11 expression exposes fragilities in the mitotic spindle, causing chromosomal instability.
Dale KL; Armond JW; Hynds RE; Vladimirou E
J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35929456
[TBL] [Abstract] [Full Text] [Related]
12. PGC1α Cooperates with foxa1 to Regulate Epithelial Mesenchymal Transition through the TCF4-TWIST1.
Fang XQ; Lee M; Lim WJ; Lee S; Lim CH; Lim JH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897813
[TBL] [Abstract] [Full Text] [Related]
13. foxa1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Orstad G; Fort G; Parnell TJ; Jones A; Stubben C; Lohman B; Gillis KL; Orellana W; Tariq R; Klingbeil O; Kaestner K; Vakoc CR; Spike BT; Snyder EL
Dev Cell; 2022 Aug; 57(15):1866-1882.e10. PubMed ID: 35835117
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract] [Full Text] [Related]
15. DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas.
Jurmeister P; Leitheiser M; Wolkenstein P; Klauschen F; Capper D; Brcic L
Lung Cancer; 2022 Aug; 170():105-113. PubMed ID: 35749951
[TBL] [Abstract] [Full Text] [Related]
16. Genomic features of Chinese small cell lung cancer.
Liu J; Zhao Z; Wei S; Li B; Zhao Z
BMC Med Genomics; 2022 May; 15(1):117. PubMed ID: 35596192
[TBL] [Abstract] [Full Text] [Related]
17. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer predictions of transcription factors mediating aberrant DNA methylation.
Detilleux D; Spill YG; Balaramane D; Weber M; Bardet AF
Epigenetics Chromatin; 2022 Mar; 15(1):10. PubMed ID: 35331302
[TBL] [Abstract] [Full Text] [Related]
19. Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast cancer Metastasis.
Li Z; Wu Y; Yates ME; Tasdemir N; Bahreini A; Chen J; Levine KM; Priedigkeit NM; Nasrazadani A; Ali S; Buluwela L; Arnesen S; Gertz J; Richer JK; Troness B; El-Ashry D; Zhang Q; Gerratana L; Zhang Y; Cristofanilli M; Montanez MA; Sundd P; Wallace CT; Watkins SC; Fumagalli C; Guerini-Rocco E; Zhu L; Tseng GC; Wagle N; Carroll JS; Jank P; Denkert C; Karsten MM; Blohmer JU; Park BH; Lucas PC; Atkinson JM; Lee AV; Oesterreich S
Cancer Res; 2022 Apr; 82(7):1321-1339. PubMed ID: 35078818
[TBL] [Abstract] [Full Text] [Related]
20. Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan.
Shiraishi T; Oda K; Yamasaki K; Kido T; Sennari K; Mukae H; Ohtani M; Fujino Y; Matsuda S; Fushimi K; Yatera K
Thorac Cancer; 2022 Jan; 13(2):236-246. PubMed ID: 34865321
[TBL] [Abstract] [Full Text] [Related]
[Next]
